Atai stock forecast.

With its shares down by 60% in the last 12 months and a recent layoff affecting 30% of its workforce, it's fair to say that Atai Life Sciences ( ATAI 1.87%) is having a rough go of things lately ...These forecasts range from $9 to $20, indicating a considerable increase compared to its previous closing price of $1.88. Over the past 12 months, ATAI’s stock has witnessed a remarkable growth ...ATA Inc-China Net Income Forecast for 2023 - 2025 - 2030. In the last year, ATA Inc-China has seen a decline in its Net Income, from $-169.84M to $-167.81M – a 1.20% decrease. In the next year, analysts predict that Net Income will reach $-169.84M – an increase of 1.21%. For the next nine years, the forecast is for Net Income to grow by 0.80%.Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ... Atai Life stock slumps 40% as depression drug fails mid-stage study. Jan. 06, 2023 8:23 AM ET Atai Life Sciences N.V. (ATAI) By: Ravikash, SA News Editor 11 Comments. Sean Anthony Eddy. Atai Life ...

25. 10. 2023. ... ... Atai in early October, with a price target of $20. Its closing price on Oct. 24 was $1.23. The very same week, Atai announced it had ...Historical and current end-of-day data provided by . All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday ...Exela Technologies Inc () Stock Market info Recommendations: Buy or sell Exela Technologies stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Exela Technologies share forecasts, stock quote and buy / sell signals below.According to present data Exela Technologies's XELA shares and potentially its …

The average Compass stock price prediction forecasts a potential upside of 35.39% from the current COMP share price of $2.43. What is COMP's forecast return on equity ...Analyst Price Forecast Suggests 644.36% Upside As of August 2, 2023, the average one-year price target for ATAI Life Sciences N.V. is 12.51. The forecasts range from a low of 5.15 to a high of $22.05.

Track ATAI Life Sciences N.V. (ATAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAtai Life Sciences has a strong financial position with $227.5 million in cash and funding to support its operations into the 1st half of 2026. The global schizophrenia drug market is expected to ...Mar 31, 2023 · Atai Life Sciences ( ATAI 2.80%), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of ... This influential firm issued a $20 share price target for ATAI, propelling its stock value to surge. As of May 24, 2023, ATAI Life Sciences boasts an average one-year price target of $13.75, as ...

Dec 1, 2023 · View atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Even in a speculative industry, I believe the stock is undervalued by these few facts alone. ATAI holds: 450M cash and cash equivalents; 20% equity stake in CMPS (750M mktcp - 150M worth at current prices); and ATAI has a vast ip pipeline that includes 9 lead compounds. Curious as to the community’s thoughts here!

CMPS Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for COMPASS Pathways in the last 3 months. The average price target is $50.17 with a high forecast of $120.00 and a low forecast of $21.00. The average price target represents a 832.53% change from the last price of $5.38.VRNOF Stock 12 Months Forecast. $8.01. (88.03% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Verano Holdings in the last 3 months. The average price target is $8.01 with a high forecast of $10.00 and a low forecast of $6.00. The average price target represents a 88.03% change from the last price of $4.26.Atai's stock is hurting, but its pipeline is still packed with promising programs. With its shares down by 60% in the last 12 months and a recent layoff …WebFind real-time ATAI - ATAI Life Sciences NV stock quotes, company profile, news and forecasts from CNN Business.WebWhat is the current Price Target and Forecast for atai Life Sciences (ATAI) atai Life Sciences (ATAI) (Delayed Data from NSDQ) $1.12 USD +0.08 (7.69%) Updated …WebMarket cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ...

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comGet ATA IMS Bhd (ATAI.KL) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.Jun 5, 2023 · ATAI stock closed at $1.76 and is up $0.10 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. ATAI has a strong overall score of 70 meaning the stock holds a better value than 70% of stocks at its current price. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Bird Global Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median ...On July 10, 2023, the stock experienced a significant increase, driven by positive forecasts and a strong consensus among investment analysts. According to data from CNN Money, the 12-month price forecasts for ATAI stock have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 6.00.Exela Technologies Inc () Stock Market info Recommendations: Buy or sell Exela Technologies stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Exela Technologies share forecasts, stock quote and buy / sell signals below.According to present data Exela Technologies's XELA shares and potentially its …

The total addressable market for AI is massive; by 2030, it's expected to be worth nearly $2 trillion, according to Statista. That's a massive pie, and multiple companies will be vying for these ...Use our graph to track the performance of ATAI stocks over time. Share price volatility. Over the last 12 months, ATAI Life Sciences's shares have ranged in ...

A. While ratings are subjective and will change, the latest ATAI Life Sciences ( ATAI) rating was a reiterated with a price target of $0.00 to $20.00. The current price ATAI Life Sciences ( ATAI ...ATAI Life Sciences. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01 ... Stock Price Forecast. The 12 analysts offering 12-month price forecasts for ATAI Life Sciences NV have a median target of 21.00, with a high estimate of 50.00 and a low estimate of 6.60. The median estimate represents a +650.00% increase from the last price of 2.80. Analyst Recommendations.CLLS Stock 12 Months Forecast. $6.33. (116.04% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $6.33 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 116.04% change from the last price of $2.93. Find the latest SoundHound AI, Inc. (SOUN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Shares of mental health biopharma Atai Life Sciences N.V. have fallen some two-thirds from their June 2021 IPO pricing as the biotech market continues to crater. See why ATAI stock is a buy.NEW YORK and BERLIN, Jan. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “the Company”), a clinical-stage biopharmaceutical company focused on mental health ...What's Happening With ATAI Life Sciences NV Stock Today? ATAI Life Sciences NV (ATAI) stock is trading at $3.05 as of 3:20 PM on Thursday, Dec 15, a drop of -$0.05, or -1.77% from the previous closing price of $3.10. The stock has traded between $2.98 and $3.10 so far today. Volume today is low.About Pre-Market Quotes. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. NVIDIA Corporation Common Stock. ATAI Life Sciences N ...Complete ATAI Life Sciences N.V. stock information by Barron's. View real-time ATAI stock price and news, along with industry-best analysis.

Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...

View atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Since Atai Life Sciences is only going public, we don’t have any forecast for the stock. Also, being a clinical-stage company, we don’t have earnings-based metrics to value the stock.This stake is worth roughly $98M as of Tuesday, March 28, based on COMPASS Pathways’ closing price of $10.23/share on that day. You can find atai’s filed 10-K from last Friday here. With ...This influential firm issued a $20 share price target for ATAI, propelling its stock value to surge. As of May 24, 2023, ATAI Life Sciences boasts an average one-year price target of $13.75, as ...ATAI Life Sciences N.V. Common Shares (ATAI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Find real-time TLRY - Tilray Brands Inc stock quotes, company profile, news and forecasts from CNN Business.Atari S.A. is an interactive entertainment company and an iconic gaming industry brand that transcends generations and audiences. The company is globally recognized for its multi-platform, interactive entertainment and licensed products.In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.On December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until the 2024 annual meeting of the Company’s stockholders, or until their respective successors are duly elected and qualified.Atai Life Sciences ( ATAI) seems focused on structuring. Investors will want to see meaningful financial results that go beyond job cuts. The psychedelic drug boom may be taking off, but one ...

ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with ...On average, Wall Street analysts predict that Atai Life Sciences Nv 's share price could reach $17.50 by Aug 14, 2024. The average Atai Life Sciences Nv stock price prediction …WebThe average Atai Life Sciences Nv stock price prediction forecasts a potential upside of 1,490.91% from the current ATAI share price of $1.10. What is ATAI's forecast return on equity (ROE) for 2023-2026?The average price target for Blue Apron Holdings Inc is $13.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $13.00 ,the lowest forecast is $13.00. The average price target represents 0.08% Increase from the current price of $12.99.Instagram:https://instagram. gunr etfnasdaq vxusdisney paramountluxurycard.com review Validation of atai's operating model and ability to capture value: IPO of COMPASS Pathways in 2020 and licensing deal between Otsuka and atai subsidiary Perception Neuroscience in 2021 Strong cash position of approx. $273M (as of December 31 st , 2022) and access to up to an additional $160m from term loan facility with Hercules 2 lead to ... steel wheat penny 1943 valuehow much is a silver half dollar worth 1964 See Atai Life Sciences N.V. (ATAI) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.On December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until the 2024 annual meeting of the Company’s stockholders, or until their respective successors are duly elected and qualified. b2b sales course The average one-year price target for ATAI Life Sciences N.V. (NASDAQ:ATAI) has been revised to 12.57 / share. This is an increase of 5.04% from the prior estimate of 11.97 …WebAtai Life Sciences (ATAI) Stock Forecast & Price Prediction. Estimation of the future price movement of Atai Life Sciences stock, based on various factors such as historical price …Web